Ex-4 significantly reduces neuroinflammation by converting proinflammatory M1 microglia into anti-inflammatory M2 microglia both in vitro and in vivo through the rescue of the expression of Arf and Rho GAP adapter protein 3 (ARAP3)
As some examples, GLP-1RAs are safer and slightly more effective in improving glucose control, significantly reducing body weight, and preventing hypoglycemia than basal insulin in poorly controlled T2D with oral antihyperglycemic agents (61)
Ipamorelin boosts GH and therewith also IGF-1, which orders fat to be burned so it can be used as energy
Apply step therapy and tie GLP-1 coverage to broader condition/change management programs for persistent change
Most products completely ignore the gut
Practical approaches might include targeted delivery to the ovary or testis, combined with standard hormonal protocols, though clinical trials are limited